Skip to main content
Independent science journalism
We do not sell or supply peptides
Peptide
Science
Daily
News
Research
Compounds
Trials
Regulatory
Safety
Trackers
Search
⌘K
Subscribe
News
Research
Compounds
Trials
Regulatory
Safety
Trackers
Theme
Subscribe to the newsletter
We do not sell or supply peptides.
Home
Trials
NCT02536898
Clinical Trials · NCT02536898
Norwegian Capture the Fracture Initiative
Completed
N/A
Teriparatide
(Approved)
Phase
N/A
Recruitment status
Completed
Sponsor
Oslo University Hospital
Enrollment
94,260
Start date
May 2015
Locations
7 sites, Norway
Primary endpoint
Fragility fracture
View Teriparatide compound reference